Cardinal Health stock

CAH · NYSE · USD

Compare Cardinal Health
$279.25Change from previous close: −1.62%Absolute change: −$4.60

Close · November 17, 2026

Price history

+36.67% over the period

1 year: from $206.18 (November 17, 2025) to $281.80 (November 17, 2026), +36.67%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$281.80
October 30, 2026$250.48
September 30, 2026$222.50
August 31, 2026$234.62
July 31, 2026$230.03
June 30, 2026$237.56
May 29, 2026$196.80
April 30, 2026$192.88
March 31, 2026$211.31
February 27, 2026$229.23
January 30, 2026$214.88
December 31, 2025$205.50
November 28, 2025$212.26
November 17, 2025$206.18

At a glance

  • The company

    Distributor of pharmaceutical, medical and surgical products and provider of healthcare supply chain solutions and services

  • Latest results

    Quarter to September 30, 2026 · EPS $3.26 (estimate $2.95)

TickerLandia's take on Cardinal Health

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$180.45
52-wk high$286.29

−2.46% from the 52-week high

Analysts · 17 analysts

Average target$294.87+5.59% vs. price

Buy 14 · Hold 3 · Sell 0 · Buy

TickerLandia Fingerprint: Cardinal Health

Compared with similar companies: very strong momentum and very low profitability.

Financials and price compared with 11 companies in the medical distribution industry, worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Cardinal Health is pricier than in the past and pricier than similar companies

On the latest fiscal year's earnings (2026), Cardinal Health's P/E today is 39.0, above the median of its last 8 fiscal years (28.0; between 10.4 and 75.1 from 2017 to 2026). Cardinal Health's P/E (trailing 12 months): 36.4, +29% against the median of a group of 11 similar companies (28.2).

P/E compared with its history

Compared with 11 similar companies

Cardinal Health's metrics compared with similar companies
MetricCardinal HealthPosition in the groupBand
P/E (trailing 12 months)36.4High
Forward P/E19.5Middle
Operating margin1.3%Low
ROE-63.6%Low
Debt/equity-3.67Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Cardinal Health. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$63.67B

Latest quarter · Q2 2026

Net income

$398M

Latest quarter · Q2 2026

Quarterly net margin

0.6%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
$64.97B
P/E
36.4
EPS
$7.73
Volume
1.25M
Daily trading
€402.46M
Dividend yield
0.74%
Last ex-dividend on October 1, 2026

How Cardinal Health is changing

All results
  • Revenue grew 9.4% a year on average over the last 5 years

  • Shares outstanding down 19.4% in 5 years

  • Profitable in 4 of 5 fiscal years

Returns

Cardinal Health returns with dividends

$1,000 invested in Cardinal Health 5 years ago, on November 17, 2021, would be worth $6,273 today with dividends reinvested: +527.31% in total, +44.38% per year. On price alone it would be $5,666 (+466.65%).

PeriodCardinal HealthS&P 500$1,000 becomes
1 month+11.54%−3.17%$1,115
6 months+43.06%+0.11%$1,431
Year to date+37.13%+8.34%$1,371
1 year+37.95%+11.15%$1,380
3 years+184.45%+64.30%$2,845
5 years+527.31%+58.18%$6,273
10 years+417.69%+239.10%$5,177

Over the last 6 months it has done better than 83% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Cardinal Health: technical analysis

Cardinal Health is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 1.6% below its highest close since January 2, 1990 ($283.85, November 16, 2026).

Trend
Upward
RSI (14 sessions)
72
Above 70: a strong rise in a short time
vs 200-session average
+23.70%

Active signals

  • RSI above 70: the stock has risen a lot in a short time.

    since November 5, 2026

Support and resistance

Price areas where Cardinal Health has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$279.25
  3. Support$258.75−7.34%2 touches, last on October 22, 2026
  4. Support$243.35−12.86%2 touches, last on October 28, 2026
  5. Support$229.24−17.91%2 touches, last on August 24, 2026

Volatility and risk

Over the last year it has moved little with the S&P 500.

Beta (1 year) vs S&P 500
−0.01
Volatility (60 sessions, annualised)
23.9%
Largest fall in the last year
−20.61%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Cardinal Health: seasonality

Average monthly price change over 37 years

+3.1%Jan+1.6%Feb+0.1%Mar−0.8%Apr+2.5%May+1.4%Jun+0.8%Jul+0.6%Aug+0.1%Sep+1.7%Oct+3.9%Nov+0.9%Dec

Over the last 37 years, the strongest month for Cardinal Health has been November: +3.89% on average, positive in 26 years out of 36. The weakest has been April: −0.78% on average, positive in 14 years out of 37.

Show chart data
MonthAverageMedianPositive years
January+3.07%+2.81%26 of 36
February+1.60%+1.97%26 of 37
March+0.11%−0.07%18 of 37
April−0.78%−1.95%14 of 37
May+2.49%+2.03%24 of 37
June+1.36%0.00%18 of 37
July+0.79%+2.55%22 of 37
August+0.61%+0.53%21 of 37
September+0.08%−0.58%18 of 37
October+1.66%+4.75%21 of 37
November+3.89%+4.05%26 of 36
December+0.92%+0.03%19 of 36

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Cardinal Health and its competitors

Customers of this US company include hospital and pharmacy operators, physicians, surgery centers, clinical laboratories and patients who receive care at home, and its activity is concentrated in the United States. Its operations are organized into two segments, one covering pharmaceuticals and specialty solutions and the other global medical products and distribution. It distributes branded, generic and over-the-counter pharmaceuticals, runs pharmacies, repackages generic drugs and supplies pharmaceutical manufacturers with services for specialty products.

Headquarters
Dublin, United States
Employees
58,788
Founded
1979
Chief executive
Jason Hollar
Cardinal Health and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Cardinal HealthCAH$64.97B1.3%36.4+43.06%
CencoraCOR$68.11B1.4%20.0+36.03%
McKessonMCK$126.04B1.6%28.2+43.53%
Henry ScheinHSIC$9.17B5.8%22.7+14.05%
Sigma HealthcareSIG$22.55B9.2%48.3+3.55%
Sinopharm Group Ltd H1099$6.68B3.0%6.51−3.31%

Same industry or related industries, similar size. Compare Cardinal Health with its competitors · Full profile